Nisa Investment Advisors
BHVN

Nisa Investment Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Nisa Investment Advisors’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,392
Closed -$640K – 2689
2022
Q2 		$640K Buy
4,392
+690
+19% +$88.1K 0.01% 966
2022
Q1 		$439K Buy
3,702
+1,021
+38% +$127K ﹤0.01% 1121
2021
Q4 		$356K Buy
2,681
+611
+30% +$77.7K ﹤0.01% 1104
2021
Q3 		$288 Hold
2,070
– – ﹤0.01% 1289
2021
Q2 		$201 Hold
2,070
– – ﹤0.01% 1409
2021
Q1 		$141 Hold
2,070
– – ﹤0.01% 1609
2020
Q4 		$177K Buy
2,070
+250
+14% +$21.2K ﹤0.01% 1521
2020
Q3 		$118K Buy
1,820
+1,280
+237% +$83.9K ﹤0.01% 1495
2020
Q2 		$39K Sell
540
-520
-49% -$27.7K ﹤0.01% 1636
2020
Q1 		$36K Sell
1,060
-285
-21% -$13K ﹤0.01% 1603
2019
Q4 		$73K Buy
1,345
+245
+22% +$12.1K ﹤0.01% 1486
2019
Q3 		$46K Buy
1,100
+920
+511% +$38.9K ﹤0.01% 1545
2019
Q2 		$8K Hold
180
– – ﹤0.01% 1830
2019
Q1 		$9K Hold
180
– – ﹤0.01% 1807
2018
Q4 		$7K Hold
180
– – ﹤0.01% 1754
2018
Q3 		$7K Buy
+180
New +$6.62K ﹤0.01% 1832

Other funds holding BHVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Nisa Investment Advisors's BHVN Position: Q3 2022 in Review

Nisa Investment Advisors sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2022, closing a stake of 4,392 shares — an estimated $640K sold.

Nisa Investment Advisors first reported a position in BHVN in Q3 2018 and held it in 16 quarters. The position peaked at $640K in Q2 2022. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

  • Nisa Investment Advisors reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2022 after selling out during the quarter.
  • Nisa Investment Advisors sold 4,392 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $640K.
  • Nisa Investment Advisors first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2018 and held it in 16 quarters.
  • Nisa Investment Advisors's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $640K in Q2 2022.
  • 240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on Nisa Investment Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.